Skip to main content
. 2019 Jun 24;9:9139. doi: 10.1038/s41598-019-45579-0

Figure 3.

Figure 3

Validation of the 4-GES in gene expression data set GSE37642, consisting of 379 cytogenetically heterogeneous AML patients. (A) Cut-off value for stratification of AML patients into 4-GESlow (blue) and 4-GEShigh (red) was calculated by maximally selected rank statistics. (B) Kaplan Meier curves for overall survival of 379 AML patients classified as 4-GESlow (blue) and 4-GEShigh (red). (C) Kaplan Meier curves for overall survival of 107 ELN favourable, 174 ELN intermediate I/II and 86 ELN adverse risk AML patients stratified into 4-GESlow (blue) and 4-GEShigh (red). Statistical significance was calculated using the log rank test and p-values were adjusted for multiple testing according to Altman et al.58. (D) Kaplan Meier curves for overall survival of AML patients stratified into favourable, intermediate, and adverse based on ELN 2010 classification (left) and ELN 2010 + 4-GES classification (right). ELN, European Leukemia Net.